Page last updated: 2024-10-27

flumazenil and Parkinsonian Disorders

flumazenil has been researched along with Parkinsonian Disorders in 3 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Research Excerpts

ExcerptRelevanceReference
"Delayed postanoxic encephalopathy is a relatively uncommon and unexplained phenomenon which becomes manifest after an initial hypoxic-ischemic event that causes stupor or coma."1.31[Delayed postanoxic encephalopathy]. ( Collantes Herrera , A; Gascón Jiménez , FJ; Navarro Gochicoa , B; Peña Rosa , MJ; Velasco Jabalquinto , MJ, 2000)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mograbi, KM1
de Castro, AC1
de Oliveira, JA1
Sales, PJ1
Covolan, L1
Del Bel, EA1
de Souza, AS1
Ihara, M1
Tomimoto, H1
Ishizu, K1
Yoshida, H1
Sawamoto, N1
Hashikawa, K1
Fukuyama, H1
Gascón Jiménez , FJ1
Navarro Gochicoa , B1
Velasco Jabalquinto , MJ1
Collantes Herrera , A1
Peña Rosa , MJ1

Other Studies

3 other studies available for flumazenil and Parkinsonian Disorders

ArticleYear
Effects of GABAa receptor antagonists on motor behavior in pharmacological Parkinson's disease model in mice.
    Physiological reports, 2017, Volume: 5, Issue:6

    Topics: Animals; Behavior, Animal; Bicuculline; Disease Models, Animal; Flumazenil; GABA-A Receptor Antagoni

2017
Association of vascular parkinsonism with impaired neuronal integrity in the striatum.
    Journal of neural transmission (Vienna, Austria : 1996), 2007, Volume: 114, Issue:5

    Topics: Aged; Aged, 80 and over; Basal Ganglia; Basal Ganglia Cerebrovascular Disease; Carbon Radioisotopes;

2007
[Delayed postanoxic encephalopathy].
    Anales espanoles de pediatria, 2000, Volume: 53, Issue:2

    Topics: Child; Coma; Diagnosis, Differential; Flumazenil; GABA Modulators; Humans; Hypoxia, Brain; Male; Par

2000